CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $12.05 million.

GUIDANCE:

CareDx sees Q4 2017 revenue of $47-49 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.